Adil Fatakia
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Asthma and respiratory diseases, SARS-CoV-2 and COVID-19 Research, Allergic Rhinitis and Sensitization, Sinusitis and nasal conditions
Most-Cited Works
- → Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial(2021)539 cited
- → Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection(2022)17 cited
- → Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study(2023)14 cited
- → Phase 2 dose-ranging study of the virologic efficacy and safety of the combination COVID-19 antibodies casirivimab and imdevimab in the outpatient setting(2021)8 cited